Company: BGLC
Filing Date: 2025-11-13
Form Type: 8-K
Source: 0001477932-25-008137
Chunk: 2

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-13
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01. Financial Statement and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                                                                                                                           
         99.1      Press Release, dated November 10, 2025.                                                                                                                                                               
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          1.1      Equity Distribution Agreement, dated November 7, 2025, between BioNexus Gene Lab Corp. and Maxim Group LLC (incorporated by reference to Exhibit 1.1 to the Registration Statement on Form S-3 (F...  
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                                                           

SIGNATURES